SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001513160-13-000065
Filing Date
2013-10-31
Accepted
2013-10-31 16:41:39
Documents
5
Period of Report
2013-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LION BIOTECHNOLOGIES CURRENT REPORT currentreport103013.htm 8-K 48549
2 FORM OF WARRANT ex41.htm EX-4.1 106835
3 SECURITIES PURCHASE AGREEMENT ex101.htm EX-10.1 283851
4 FORM OF REGISTRATION RIGHTS AGREEMENT ex102.htm EX-10.2 158652
5 PRESS RELEASE DATED OCTOBER 31, 2013 ex991.htm EX-99.1 8938
  Complete submission text file 0001513160-13-000065.txt   608255
Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 131183222
SIC: 4731 Arrangement of Transportation of Freight & Cargo